Health
UK pediatrician who led review of child ‘transitions’ says US medical groups ‘misleading the public’

Dr. Hilary Cass, author of the Cass Review
From LifeSiteNews
The American Academy of Pediatrics’ support for surgically and chemically mutilating gender-confused children ‘is now demonstrated to be out of date by multiple systematic reviews,’ Dr. Hilary Cass told the New York Times.
The typically left-wing New York Times published an interview on Monday with consultant pediatrician Dr. Hilary Cass on her comprehensive review of so-called “gender medicine” in the United Kingdom, indicating that awareness of the damage due to surgical and chemical “transitioning” continues to spread despite the best efforts of LGBT activists.
Released in April, 366-page Cass Review was commissioned by National Health Service (NHS) England following ongoing scandals about the practices of British “gender clinics” such as the Gender Identity Development Service (GIDS), operated by the Tavistock and Portman NHS Foundation Trust. The four-year project consisted of comprehensive reviews of current research and international standards, as well as extensive interviews with gender-confused children and adults, family members, detransitioners, doctors, and activists.
It found that “gender medicine” is “built on shaky foundations” and that while such interventions require a great deal of caution, “quite the reverse happened in the field of [so-called] gender care for children,” and that “[w]hile a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.” Her findings led NHS to stop prescribing puberty blockers to children with gender confusion earlier this year.
Speaking to the Times, Cass explained that she was planning her retirement when she was first asked to tackle the project and was initially apprehensive about wading into the controversy.
“The most important concern for me is just how poor the evidence base is in this area,” she said. “Some people have questioned, ‘Did we set a higher bar for this group of young people?’ We absolutely didn’t. The real problem is that the evidence is very weak compared to many other areas of pediatric practice.”
The Times acknowledged that her “findings are in line with several European countries that have limited the treatments [sic] after scientific reviews. But in America, where nearly two dozen states have banned the care outright, medical groups have endorsed the treatments as evidence-based and necessary,” including groups the paper contacted for its latest story. Cass described American medical consensus as “out of date” on the issue.
“When I was president of the Royal College of Pediatrics and Child Health, we did some great work with the A.A.P. [American Academy of Pediatrics],” she elaborated. “They are an organization that I have enormous respect for. But I respectfully disagree with them on holding on to a position that is now demonstrated to be out of date by multiple systematic reviews.”
“It wouldn’t be too much of a problem if people were saying ‘This is clinical consensus and we’re not sure,” she added. “But what some organizations are doing is doubling down on saying the evidence is good. And I think that’s where you’re misleading the public. You need to be honest about the strength of the evidence and say what you’re going to do to improve it.”
A significant body of evidence shows that “affirming” gender confusion carries serious harms, especially when done with impressionable children who lack the mental development, emotional maturity, and life experience to consider the long-term ramifications of the decisions being pushed on them.
Studies find that more than 80% of children experiencing gender dysphoria outgrow it on their own by late adolescence, and that even full “reassignment” surgery often fails to resolve gender-confused individuals’ heightened tendency to engage in self-harm and suicide — and may even exacerbate it, including by reinforcing their confusion and neglecting the actual root causes of their mental strife.
Yet while mounting evidence against youth “gender transitions” is prompting European nations such as the United Kingdom and France, which are normally to the left of America, to move away from the practice, in America, the medical establishment and the Biden administration continues to dig in their heels, despite Biden’s own Substance Abuse & Mental Health Services Administration (SAMHSA) releasing a since-deleted report last year acknowledging that “lesbian, gay, and bisexual adults are more likely than straight adults to use substances, experience mental health conditions including major depressive episodes, and experience serious thoughts of suicide.”
The White House’s comprehensive pursuit of the transgender agenda has included reopening the military to recruits afflicted with gender dysphoria, promoting gender ideology within the military (including “diversity” and drag events on military bases), holding White House events to “affirm transgender kids,” condemning state laws against underage “transitions” as “close to sinful,” promoting underage “transitions” (potentially at taxpayer expense) as a “best practice,” and trying to force federally funded schools to let males into female athletic competitions and restrooms.
Business
Canadians continue to experience long waits for MRIs and CT scans

From the Fraser Institute
Canada reported 10.6 MRI machines per million population, ranking us 27th out of 31 universal health-care countries and far behind fifth-ranked Germany (32.5 machines per million population). We see a similar story with CT scanners where second-ranked Australia (78.5 units per million) far outpaces Canada (14.6 units per million population)
Canada’s health-care system is in dire straits. We face an access crisis in primary care, regular rural emergency room closures, and some of the longest waits for non-emergency surgery in more than 30 years. Indeed, the median wait between referral to a specialist by a general practitioner and receipt of treatment was 30 weeks in 2024, the longest on record.
But beyond medical and surgical treatments, Canadians also face significant waits for key diagnostic services.
In 2024, the latest year of available data, patients could expect a 16.2-week wait for an MRI (more than three weeks longer than what they waited in 2023) and an 8.1-week wait for a CT scan (a week and half longer than in 2023).
Of course, these machines are crucial in the diagnosis and monitoring of many different illnesses. As a result, long waits for these machines can result in delays in diagnosis and the advancing of illness that can impact decisions around treatment and potential outcomes.
But why are there delays for this type of basic diagnostic care?
One explanation is that Canada has lower availability of these machines compared to other high-income universal health-care systems.
For example, using the latest available data from 2022 and after adjusting for population age, Canada reported 10.6 MRI machines per million population, ranking us 27th out of 31 universal health-care countries and far behind fifth-ranked Germany (32.5 machines per million population). We see a similar story with CT scanners where second-ranked Australia (78.5 units per million) far outpaces Canada (14.6 units per million population), which ranked 28th of 31.
These data also underscore the wider dissatisfaction among Canadians about how our governments steward our health-care systems. According to a recent Navigator poll, 73 per cent of Canadians want major health-care reform.
In the end, poor access to diagnostic imaging technology can prevent the appropriate triaging of patients and create further delays for scheduled care. Improving access to diagnostic imaging should help reduce delays for care overall and improve the lives of patients and their families.
Brownstone Institute
The Latest “Bird Flu” Psyop

From Brownstone Institute
By
I am expert in influenza, and have consulted with the WHO over the past two decades on the topic of flu vaccines. This is one subject matter I am extremely knowledgeable about. This goes back to my medical school days, when I worked with Robert Lamb, one of the top influenza virus specialists in the world. It extended through much of my career, including my serving as Director of Clinical Influenza Vaccine Research for Solvay Biologicals, in which I oversaw over $200 million in federal (BARDA) alternative (cell-based) influenza vaccine research funding.
What is happening now with “Bird flu” is another psyops campaign being conducted by the administrative/deep state, apparently in partnership with Pharma, against the American people. They know and we know that the “vaccines” being produced will be somewhat ineffective, as all flu “vaccines” are. The government is chasing a rapidly evolving RNA virus with a syringe, just like they did with HIV and Covid-19.
Generally, the currently circulating avian influenza strain in the US does not include any cases of human-to-human transmission. And the current mortality, with over 60 cases identified, is 0%. NOT 50%.
All the while they are getting prepared to roll out masks, lockdowns, quarantines, etc.
All the while getting ready to roll out mRNA vaccines for poultry and livestock, as well as for all of us.
The more they test, the more “Bird flu” (H5N1) they will find. This “pandemic” is nothing more than an artifact of their newly developed protocols to test cattle, poultry, pets, people, and wildlife on a massive scale for avian influenza. In years past, this was not even considered. In the past, the USG did fund a massive testing and surveillance program called “Biowatch.” That program was a colossal failure and a massive waste of money. Billions of dollars.
Of course, these facilities producing the tests have been repurposed from the Covid-19 testing facilities.
Key questions include:
Will we all comply?
Will we be forced to comply?
Will President Trump go along with the PsyWar/psyops campaign again?
We will know soon enough.
As the United States is testing everyone who has even the mildest symptoms for the H5N1 (avian) influenza, guess what – they are finding it! This is what we call in the lab, a “sampling bias.”
Globally, from 1997 until the present, there have been 907 reported cases of H5N1. And in fact, this particular outbreak was not the worst – and it is the only one where a massive testing campaign has occurred. It appears that this is partly due to the new diagnostic capabilities developed and deployed during Covid-19. The more you test, the more you find. But is it clinically significant?

The Case Study of Tetanus: Supply Chain Issues.
The CDC recommends a booster for the tetanus vaccine every 10 years for adults.
However, research published almost a decade ago suggests that the protection from tetanus and diphtheria vaccination lasts at least 30 years after completing the standard childhood vaccination series.
“We have always been told to get a tetanus shot every 10 years, but actually, there is very little data to prove or disprove that timeline. When we looked at the levels of immunity among 546 adults, we realized that antibody titers against tetanus and diphtheria lasted much longer then previously believed.”
-Mark K. Slifka, Ph.D, study author
This research, published in a highly reputable journal, suggests that a revised vaccination schedule with boosters occurring at ages 30 and 60 would be sufficient. As this was published in early 2016, the US government, at the very least, could have commissioned easily designed prospective and retrospective studies to confirm these results. And those results would have been published by now, with the tetanus adult schedule revised to reflect what is now known about the durable immunity of tetanus and diphtheria vaccines. Reducing the boosters to just two shots would save the government vast sums of money.
Not only that, but both the tetanus and diphtheria vaccines carry risks for adults. It is estimated that 50%–85% of patients experience injection site pain or tenderness, 25%–30% experience edema and erythema. Higher preexisting anti-tetanus antibody levels are also associated with a higher reactogenicity rate and greater severity (reference).
Anaphylaxis after tetanus vaccination represents a rare but potentially serious adverse event, with an incidence of 1.6 cases per million doses. That means if 100 million adults receive the booster every ten years, 320 cases of anaphylaxis will be avoided over the 30-year period – from those two boosters being eliminated. Tetanus has always been a “rare” disease, spread through a skin wound contaminated by Clostridium tetani bacteria, commonly found in soil, dust, and manure. Before vaccines were available, there were about 500 cases a year, with most resulting in death. Concerns about vaccine-associated adverse events when immunizations were performed at short intervals led to a revision of the tetanus/diphtheria vaccination schedule in 1966 to once every 10 years for patients >6 years of age.
It has recently come to my attention that the traditional stand-alone tetanus vaccine (TT) that one used to receive as an adult has been discontinued due to WHO recommendations. Their reasoning being:
Use of TTCV combinations with diphtheria toxoid are strongly encouraged and single-antigen vaccines should be discontinued whenever feasible to help maintain both high diphtheria and high tetanus immunity throughout the life course.
The CDC blames the shuttering of the only plant producing TT for the current lack of a stand-alone TT vaccine.
Now, in order to get a booster tetanus shot, an adult must take the following.
- Td: Sanofi’s Tenivac protects against tetanus and diphtheria. Given to people 7 years and older as a booster every 10 years. *A version also includes pertussis (eg DPT), but due to the risk of encephalitis, it is not recommended as a booster.
Why is the DPT combination vaccine discouraged in adults due to encephalitis risk, but is it recommended for children? Another one of those inconvenient issues that plague the CDC-recommended childhood vaccine schedule.
While supplies of diphtheria, tetanus, and pertussis (Tdap) vaccines (Sanofi’s Adacel and GSK’s Boostrix) aren’t limited, they are more expensive, and a very small fraction of patients can develop encephalopathy (brain damage) from the pertussis component.
In the United States, diphtheria is virtually non-existent, with only 14 cases reported between 1996 and 2018. Of those cases reported, most were from international travelers or immigrants.
The market for a stand-alone TT vaccine vanished worldwide due to WHO recommendations to stop the sales of the TT vaccine. Which was due to the relatively few, economically stressed countries where diphtheria is still an issue. So, therefore, the only facility manufacturing the TT vaccine was shut down within the last year.
The blowback from the WHO recommendations is that now there is a shortage of tetanus and diphtheria (Td) vaccine in the United States, according to the Centers for Disease Control and Prevention (CDC) website.
This all comes down to poor planning. And illustrates why supply chain issues and infectious disease countermeasure stockpiles are essential considerations for governments.
The good news is that unless one is immunosuppressed, most of us have almost lifelong immunity against tetanus and diphtheria.
My recommendation is that unless one gets a very deep and dirty puncture wound and has not had a tetanus shot in over ten years or longer, avoid that booster.
Here is the ugly secret about influenza vaccines. They are given to protect one group of vulnerable people. Those who are immunosuppressed, and that cohort includes the very elderly.
If those influenza vaccine manufacturing plants only make enough vaccines for those susceptible to a severe case of the flu, there would not be enough of a market to sustain their production costs. Furthermore, if there were a pandemic of some sort of highly pathogenic influenza, there would not be sufficient capacity to make enough vaccines to meet demand.
Egg-based influenza vaccine production requires super “clean” eggs; about 100 million “clean” fertilized eggs are needed annually for vaccine production in the US alone. Candidate vaccine viruses are injected into the eggs. If the process is shuttered, the whole production comes to a screeching halt. Many vaccines can be stored for long periods. Even as long as a decade. This stockpiling system works well for DNA viruses with a low mutation rate. Stockpiling is rarely a solution for vaccines developed for RNA viruses that mutate rapidly.
Therefore, the influenza vaccine is pushed on the American people year after year. As a way to maintain “warm base manufacturing” and ensure sufficient market size to support industrial operations.
I have spoken on this subject at the WHO and US government agencies, as well as many, many conferences. Unfortunately, because the mRNA and RNA vaccine platforms require a lot of freezer space (commonly -20°C) to stockpile for even short periods, this limits the ability to stockpile. Furthermore, the frozen storage requirements are only for up to 6 months. That means stockpiling for more extended storage is not currently done, and it is back to square one on the supply chain issue.
The issue with freezer space and mRNA vaccines is one that most likely won’t be solved. This benefits the manufacturers of this vaccine technology – the US government has an endless need for new vaccines as the old ones expire.
My small hope is that the mRNA platform will be too costly to justify its continued use, as appeals concerning safety (or lack of) seem to fall on deaf FDA ears.
In the meantime, don’t believe the hype generated by ex-officials from the Biden and Trump administrations.

Both Dr. Lena Wen, CNN correspondent, and Dr. Redfield, ex-director of the CDC, have gone on to mainstream media shows and promoted the narrative that the case fatality rate for avian influenza is over 50 percent. This, frankly, is a lie that the WHO is promoting. Bird flu generally is not tested for when someone has flu symptoms. When an outbreak of avian flu occurs on a poultry farm, testing of farm workers who are seriously ill will commence. This has led to the generation of the 890 case reports since 2003. Of those seriously ill patients reported to the WHO, over 50 percent died.
This is not an actual case fatality rate of avian flu around the world. It is, again, a sampling error due to a tiny data set derived from those who are at greatest risk due to general health. And just like the WHO reported on an exaggerated case fatality rate for mPOX, which was also based on a sampling error, or for Covid-19, again a sampling error, it is now used to justify psychological bioterrorism on the world population. Please don’t fall for it.
El Gato Malo on X succinctly points out that Dr. Leana Wen and her public health ilk are advancing:
1. Do more of the same lousy testing used in Covid-19 to overstate a disease and cause panic.
2. Develop another non-sterilizing non-vaccine that does not work to be pushed on “the vulnerable.”
3. Doing it “right now” under EUA, so whoever makes these tests and jabs can cash in and be shielded from liability.
4. Claiming that proxies like “triggers antibody production” demonstrate clinical clinical efficacy.
It’s just one last smash-and-grab for cash before the Brandon (Biden) administration ends. Anyone who falls for this one will truly fall for anything.
Question: what are Leana’s conflicts of interest? Who is paying her or giving her grants?
For those that haven’t viewed Dr. Redfield speaking of the avian flu case fatality rate, have a watch below. It is genuinely shocking. This fear-mongering comes from an ex-director of the CDC. Shame on him.
Frankly, it reminds me of the 51 intelligence officials claiming that Hunter Biden’s laptop was fake.
One has to wonder what conflict of interest motivated him to say this on national TV?
Remember in the US, there have been 62 cases of avian influenza discovered, and all but one case were very mild.
This deep dive into the supply chain issues is meant to show that public health has put itself into a groupthink situation that it can’t escape.
Many solutions to this quandary do not involve an evermore expanding schedule of vaccinations, stockpiled for some future use. I have some general thoughts before I sign off.
- The use of early treatments via safe, proven drugs is a good solution.
- We now have many antibiotics to treat bacterial infections. Vaccines do not always need to be our first defense.
- Our medical system is very good at treating infectious diseases. The risks from such diseases are much less than it once was. People do not have to live in fear of infectious disease. I like to ask people, how many people do you know have died of flu? If you know of any (I don’t), how old were they?
- The need to scare people into more and more vaccines is a dangerous trend.
- And yes, the more vaccinations one receives, the more likely an adverse event.
- Vaccinating pregnant women and babies should always be a last resort.
- It is time for Congress to rethink the vaccine liability laws.
Republished from the author’s Substack
-
International2 days ago
Shocking images appear to show FBI agent with gun drawn raiding bedroom of J6 protester’s baby
-
Business1 day ago
Trump signs executive order returning to plastic straws
-
Daily Caller2 days ago
Kevin O’Leary Says Trump’s Tariffs A Gateway To US-Canada Economic Unity
-
COVID-192 days ago
Media failing to cover ‘powerful testimony’ of people injured by COVID vaccines
-
Bruce Dowbiggin2 days ago
All Bets Are Off: Why Prop Betting Scares Sports Leagues, Police
-
Business2 days ago
Canada: It’s Time to Stop Holding Ourselves Back – Lynn Exner
-
Business2 days ago
Judge blocks Musk’s Department of Government Efficiency from accessing Treasury records
-
Business2 days ago
FEMA Quietly Slid $59 Million Out The Door For Illegal Migrants To Put Their Feet Up At ‘Luxury Hotels’: Musk